Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acai seed extract is a polyphenol-rich botanical substance derived from the seeds of the *Euterpe oleracea* Mart. palm, which are typically considered agro-industrial waste. Unlike the fruit pulp, which is high in anthocyanins, the seed extract is characterized by a high concentration of condensed tannins (procyanidins), catechin, and epicatechin. In the context of metabolic disorders such as obesity (DOID:9970), the extract demonstrates significant antioxidant, anti-inflammatory, and anti-dyslipidemic activities. Its mechanism of action involves the modulation of lipid metabolism, reduction of pro-inflammatory cytokines, and the enhancement of endothelial function through nitric oxide-dependent pathways. Research indicates that it may reduce weight gain, improve insulin sensitivity, and lower blood pressure in models of metabolic syndrome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acai seed extract.